Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ABCA2,ATP-binding cassette sub-family A member 2,17937,539,2.02 [1.63-2.52],3.090595983533035e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",20960,653,1.36 [1.25-1.48],2.8256847846398114e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACAN,Aggrecan core protein,21234,667,0.32 [0.25-0.42],7.028157871121716e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE,Angiotensin-converting enzyme,18602,560,3.30 [2.44-4.45],6.592786242914026e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACE2,Angiotensin-converting enzyme 2,21059,656,1.71 [1.53-1.91],3.2833716604864973e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP1,Low molecular weight phosphotyrosine protein phosphatase,18027,543,0.63 [0.51-0.78],1.627716379861199e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACP5,Tartrate-resistant acid phosphatase type 5,21535,673,2.44 [1.97-3.01],1.584177383656491e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACRV1,Acrosomal protein SP-10,18027,543,1.24 [1.14-1.33],8.233441744967476e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACTA2,"Actin, aortic smooth muscle",21059,656,1.68 [1.47-1.91],9.41639677175134e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACVRL1,Serine/threonine-protein kinase receptor R3,21218,660,2.90 [2.30-3.65],1.6635596020504128e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY1,Aminoacylase-1,21458,675,1.61 [1.45-1.79],1.8538624349333093e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,17937,539,1.63 [1.42-1.88],1.1498087062315898e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADA2,Adenosine deaminase 2,21352,664,3.81 [3.29-4.42],3.1808944252442706e-71
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,18027,543,3.00 [2.47-3.64],7.559823083173141e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,21059,656,2.27 [1.80-2.86],4.1870472663692626e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,21257,660,1.67 [1.38-2.02],1.3289496492348257e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,21702,676,1.75 [1.41-2.17],4.752356109009677e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,21617,672,1.60 [1.27-2.02],5.553059257607738e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,18515,555,4.90 [3.87-6.21],1.1280425022557748e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADAMTSL2,ADAMTS-like protein 2,18578,554,5.23 [4.32-6.33],6.184096502711078e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRB3,Adhesion G protein-coupled receptor B3,21218,660,2.65 [2.15-3.26],5.0818019532104803e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE1,Adhesion G protein-coupled receptor E1,18515,555,1.48 [1.28-1.72],1.4097336151117084e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE2,Adhesion G protein-coupled receptor E2,21531,674,3.24 [2.56-4.10],1.0053822948640286e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRE5,Adhesion G protein-coupled receptor E5,21612,676,3.17 [2.59-3.89],4.8242876236689227e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG1,Adhesion G-protein coupled receptor G1,21362,668,2.03 [1.91-2.16],4.1729209861018417e-109
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADGRG2,Adhesion G-protein coupled receptor G2,21458,675,0.18 [0.14-0.23],6.984219172186063e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADIPOQ,Adiponectin,18598,555,0.74 [0.66-0.84],2.171790193945436e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ADM,Pro-adrenomedullin,21645,675,5.63 [4.30-7.36],1.5647046377534245e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AFP,Alpha-fetoprotein,21178,659,0.52 [0.46-0.59],2.3975117816593743e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR2,Anterior gradient protein 2 homolog,20825,638,1.55 [1.44-1.66],3.357254930824402e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGR3,Anterior gradient protein 3,20929,653,1.51 [1.35-1.69],6.210228939863097e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRN,Agrin,21531,674,3.08 [2.62-3.63],2.1600249631594318e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGRP,Agouti-related protein,21702,676,1.33 [1.15-1.52],6.660127488258529e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AGXT,Serine--pyruvate aminotransferase,21458,675,1.53 [1.40-1.68],2.280188961674439e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",21332,668,1.15 [1.08-1.23],3.865657037738923e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AK1,Adenylate kinase isoenzyme 1,21458,675,0.79 [0.70-0.89],6.94090595674146e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR1B10,Aldo-keto reductase family 1 member B10,18078,551,1.58 [1.42-1.75],3.6188174520244267e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AKR7L,Aflatoxin B1 aldehyde reductase member 4,18027,543,1.29 [1.15-1.45],1.640880344335387e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALCAM,CD166 antigen,21718,679,4.62 [3.32-6.42],8.134248377456279e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",21384,667,1.36 [1.25-1.48],7.074204070834918e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ALPI,Intestinal-type alkaline phosphatase,18027,543,1.19 [1.11-1.28],7.566792453755093e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMBP,Protein AMBP,21610,674,8.93 [6.50-12.26],1.0095065174910816e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMIGO2,Amphoterin-induced protein 2,21362,668,2.16 [1.61-2.91],3.676040630386485e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AMOT,Angiomotin,18156,548,1.56 [1.25-1.95],7.882601740522693e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANG,Angiogenin,21419,666,1.99 [1.63-2.44],1.309025558069428e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPT2,Angiopoietin-2,21645,675,2.93 [2.48-3.45],5.017910511389819e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL3,Angiopoietin-related protein 3,21493,668,0.35 [0.29-0.43],1.504925606787491e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL4,Angiopoietin-related protein 4,21497,674,2.81 [2.40-3.29],2.458099001198395e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANGPTL7,Angiopoietin-related protein 7,21645,675,2.42 [2.03-2.90],3.633336964134272e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA10,Annexin A10,20982,646,1.35 [1.24-1.46],3.992222121169888e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ANXA5,Annexin A5,20904,643,1.88 [1.49-2.37],8.504078890409918e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APCS,Serum amyloid P-component,18439,553,0.28 [0.22-0.36],3.4666675537980376e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APLP1,Amyloid-like protein 1,21458,675,0.73 [0.63-0.84],1.3559801845258304e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA1,Apolipoprotein A-I,18598,555,0.15 [0.10-0.21],7.596940675229638e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOA4,Apolipoprotein A-IV,18598,555,3.70 [3.10-4.43],7.836920548069037e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOC1,Apolipoprotein C-I,18570,555,0.19 [0.15-0.24],1.983777359686961e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOD,Apolipoprotein D,17788,538,0.16 [0.12-0.21],3.355643231112697e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOE,Apolipoprotein E,18598,555,0.62 [0.52-0.73],3.69690581144932e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOF,Apolipoprotein F,18602,560,0.43 [0.34-0.54],1.853021003307254e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOH,Beta-2-glycoprotein 1,21457,669,1.79 [1.50-2.14],1.8582488753541687e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOL1,Apolipoprotein L1,18602,560,0.46 [0.38-0.55],1.837814634019113e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,APOM,Apolipoprotein M,21527,669,0.14 [0.11-0.17],1.3015205577368522e-60
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AREG,Amphiregulin,21362,668,4.52 [3.92-5.21],2.461924874162768e-95
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ARHGAP1,Rho GTPase-activating protein 1,20960,653,0.72 [0.61-0.85],9.055797193951042e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ART3,Ecto-ADP-ribosyltransferase 3,21560,669,1.61 [1.34-1.95],5.483952716157404e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR1,Asialoglycoprotein receptor 1,21257,660,4.57 [3.71-5.64],9.8323930358604e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ASGR2,Asialoglycoprotein receptor 2,18602,560,2.85 [2.13-3.80],1.0736909907475337e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ATRAID,All-trans retinoic acid-induced differentiation factor,18515,555,2.59 [2.13-3.15],1.792741129628766e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,AXL,Tyrosine-protein kinase receptor UFO,21560,669,2.52 [1.96-3.23],5.534128769587211e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B2M,Beta-2-microglobulin,18598,555,2.17 [1.82-2.59],1.0710903111683965e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",18068,542,5.58 [4.39-7.11],2.972485799430555e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,B4GALT1,"Beta-1,4-galactosyltransferase 1",21531,674,3.16 [2.50-4.00],6.875750605547309e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,20960,653,1.63 [1.48-1.81],8.620357697406282e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BAMBI,BMP and activin membrane-bound inhibitor homolog,20960,653,2.70 [2.19-3.32],6.032894552523773e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAM,Basal cell adhesion molecule,21457,669,2.05 [1.57-2.67],1.3004094928232153e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCAN,Brevican core protein,21257,660,0.29 [0.23-0.35],1.4020874644892662e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",21422,667,1.77 [1.45-2.16],1.3543203677733373e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BGLAP,Osteocalcin,18578,554,0.70 [0.64-0.77],6.38448979518416e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BLMH,Bleomycin hydrolase,21718,679,0.55 [0.43-0.69],4.558950952817057e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMP10,Bone morphogenetic protein 10,18156,548,2.39 [1.75-3.25],3.657177210224836e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BMPER,BMP-binding endothelial regulator protein,18156,548,6.43 [4.60-8.99],1.0713782469133619e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,18027,543,1.53 [1.28-1.83],2.282429906626364e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BOC,Brother of CDO,21059,656,4.14 [3.04-5.65],2.443951834341681e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BSG,Basigin,21667,674,3.38 [2.46-4.64],5.3851578004571934e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,21651,672,1.48 [1.22-1.80],6.285767837295091e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BST2,Bone marrow stromal antigen 2,21651,672,1.43 [1.26-1.61],9.083815329316194e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN2A1,Butyrophilin subfamily 2 member A1,21531,674,4.18 [3.37-5.20],2.353241668638853e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,BTN3A2,Butyrophilin subfamily 3 member A2,21422,667,1.79 [1.50-2.12],3.6410692687523366e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C19orf12,Protein C19orf12,20982,646,1.23 [1.11-1.35],4.5494233518476855e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QA,Complement C1q subcomponent subunit A,21601,672,2.24 [1.65-3.04],1.949679400202145e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,21560,669,2.16 [1.87-2.51],1.338048468410626e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C1RL,Complement C1r subcomponent-like protein,18564,555,3.45 [2.20-5.41],6.411468840463527e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C2,Complement C2,21527,669,6.51 [4.45-9.52],5.300922595889887e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,C7,Complement component C7,18149,547,6.74 [5.33-8.52],4.716430530131848e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA12,Carbonic anhydrase 12,21362,668,3.65 [3.05-4.36],7.39642386767391e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA5A,"Carbonic anhydrase 5A, mitochondrial",21059,656,1.28 [1.18-1.37],2.4184477895637125e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA6,Carbonic anhydrase 6,21394,665,0.61 [0.55-0.69],6.52638405930141e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CA9,Carbonic anhydrase 9,21645,675,2.07 [1.83-2.35],4.459116242827333e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALB1,Calbindin,21362,668,1.70 [1.46-1.99],2.1834271109671177e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALB2,Calretinin,20982,646,2.04 [1.65-2.53],6.536068135221029e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCA,Calcitonin,21229,659,1.32 [1.20-1.45],2.3151904789255957e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CALCB,Calcitonin gene-related peptide 2,18536,557,1.61 [1.36-1.91],2.7689133770122065e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CAPG,Macrophage-capping protein,21306,662,1.28 [1.14-1.44],4.928509909406449e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBLIF,Cobalamin binding intrinsic factor,21429,675,1.69 [1.54-1.85],1.4280335087123064e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CBS,Cystathionine beta-synthase,18068,542,1.37 [1.18-1.60],3.969802553307277e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL11,Eotaxin,21702,676,3.15 [2.59-3.82],5.860996675932595e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL14,C-C motif chemokine 14,21419,666,1.55 [1.33-1.81],2.050568539103948e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL15,C-C motif chemokine 15,21718,679,2.97 [2.59-3.42],8.90760543775013e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL16,C-C motif chemokine 16,21718,679,1.46 [1.27-1.68],9.559373409818853e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL20,C-C motif chemokine 20,21702,676,1.33 [1.24-1.43],1.2219932053043347e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL21,C-C motif chemokine 21,21531,674,1.99 [1.73-2.30],4.687999316472825e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCL25,C-C motif chemokine 25,21702,676,1.94 [1.68-2.25],6.876096956710336e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN3,CCN family member 3,21679,679,1.78 [1.49-2.14],4.1072997321963407e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN4,CCN family member 4,21645,675,2.28 [1.94-2.69],5.214667912805724e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCN5,CCN family member 5,21457,669,1.81 [1.52-2.17],5.938880328972355e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CCS,Copper chaperone for superoxide dismutase,21257,660,0.60 [0.51-0.71],5.60066373983793e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD101,Immunoglobulin superfamily member 2,18515,555,1.76 [1.44-2.15],2.505999721769324e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD109,CD109 antigen,21457,669,2.66 [2.14-3.31],1.3245298180935078e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD14,Monocyte differentiation antigen CD14,21052,656,2.03 [1.71-2.40],5.307401407405657e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD160,CD160 antigen,21702,676,2.11 [1.84-2.40],5.902110484864723e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD163,Scavenger receptor cysteine-rich type 1 protein M130,21560,669,2.34 [2.01-2.73],4.028288619867965e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD164,Sialomucin core protein 24,21457,669,1.91 [1.56-2.32],2.06542235515173e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD1C,T-cell surface glycoprotein CD1c,21517,671,0.41 [0.32-0.54],9.317443016142559e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD200,OX-2 membrane glycoprotein,21422,667,1.66 [1.30-2.11],3.579249471266428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD207,C-type lectin domain family 4 member K,20981,654,2.40 [2.00-2.88],3.753896425502664e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD244,Natural killer cell receptor 2B4,21702,676,1.97 [1.55-2.52],3.856707388629732e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD248,Endosialin,18578,554,0.46 [0.37-0.56],1.859692847329582e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD27,CD27 antigen,21517,671,3.32 [2.89-3.83],1.7654565379605294e-62
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD274,Programmed cell death 1 ligand 1,21257,660,2.17 [1.81-2.60],8.676401868252167e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD276,CD276 antigen,21422,673,4.84 [3.95-5.92],5.605083681863465e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD28,T-cell-specific surface glycoprotein CD28,20960,653,2.06 [1.75-2.42],2.248436878743526e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300A,CMRF35-like molecule 8,18156,548,2.30 [1.78-2.98],1.6414550968303548e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300C,CMRF35-like molecule 6,21651,672,2.33 [1.94-2.80],1.6643959796379212e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300E,CMRF35-like molecule 2,21586,672,2.07 [1.78-2.41],6.454141743270319e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD300LF,CMRF35-like molecule 1,21645,675,1.40 [1.24-1.58],3.2675085818521015e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD302,CD302 antigen,21362,668,3.46 [2.87-4.17],2.338079544080924e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD34,Hematopoietic progenitor cell antigen CD34,21586,670,0.36 [0.26-0.48],2.004869809399537e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD36,Platelet glycoprotein 4,18027,543,1.47 [1.23-1.75],2.4590808044329205e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,21362,668,2.02 [1.65-2.47],8.751028495504619e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD4,T-cell surface glycoprotein CD4,21386,667,2.03 [1.66-2.49],5.191781320737544e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD40,Tumor necrosis factor receptor superfamily member 5,21424,672,1.33 [1.16-1.53],3.896303881504867e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD46,Membrane cofactor protein,21357,663,2.52 [2.02-3.15],2.1621856045936078e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD48,CD48 antigen,21497,674,3.44 [2.78-4.27],1.8370446666159254e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD5,T-cell surface glycoprotein CD5,21610,674,2.63 [2.21-3.14],2.1148524037950342e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD59,CD59 glycoprotein,20712,643,3.13 [2.45-4.00],6.789257722788988e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD7,T-cell antigen CD7,17999,542,1.92 [1.62-2.27],4.0797160194737976e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD72,B-cell differentiation antigen CD72,18156,548,1.75 [1.47-2.08],3.089975800359102e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD74,HLA class II histocompatibility antigen gamma chain,21651,672,3.12 [2.61-3.74],6.813490204656741e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,21702,676,2.16 [1.90-2.45],2.402027330726707e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD80,T-lymphocyte activation antigen CD80,18578,553,3.43 [2.79-4.22],1.2180921352974915e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD83,CD83 antigen,21422,667,2.23 [1.85-2.68],2.2152026657037176e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD8A,T-cell surface glycoprotein CD8 alpha chain,21651,672,1.72 [1.51-1.96],3.8882268931234283e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CD99,CD99 antigen,21457,669,2.61 [1.88-3.63],9.5402689385466e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDCP1,CUB domain-containing protein 1,21257,660,1.69 [1.50-1.89],2.809362882762757e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH1,Cadherin-1,20765,652,3.09 [2.72-3.50],8.119749453207292e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH15,Cadherin-15,21623,671,1.64 [1.51-1.78],5.732789224510106e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH17,Cadherin-17,21458,675,2.07 [1.89-2.28],1.4152899788365912e-53
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH2,Cadherin-2,21458,675,2.53 [2.08-3.09],1.9953059452269627e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH3,Cadherin-3,21651,672,1.81 [1.52-2.16],5.3560225236412175e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDH6,Cadherin-6,21458,675,2.06 [1.73-2.44],3.9818675533732073e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CDNF,Cerebral dopamine neurotrophic factor,21362,668,1.50 [1.23-1.81],4.412572304745727e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,18257,549,1.50 [1.29-1.75],1.675046889577623e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,20692,648,1.26 [1.14-1.40],1.553462572762161e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,18578,554,1.42 [1.19-1.69],9.21595710026526e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,21059,656,1.41 [1.23-1.62],7.882108635017834e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CEMIP2,Cell surface hyaluronidase,18027,543,1.60 [1.31-1.95],3.009910732066528e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CES2,Cocaine esterase,21362,668,1.50 [1.33-1.68],1.4284152945298683e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFB,Complement factor B,18281,551,2.13 [1.62-2.79],4.110498322772722e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFC1,Cryptic protein,20960,653,1.87 [1.65-2.12],2.180821658552595e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR2,Complement factor H-related protein 2,18470,552,1.41 [1.19-1.66],5.293397260611341e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR4,Complement factor H-related protein 4,18558,555,0.79 [0.71-0.89],5.703768955509951e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFHR5,Complement factor H-related protein 5,18377,553,0.61 [0.51-0.74],2.3796845283110346e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFI,Complement factor I,18598,555,2.93 [1.88-4.57],2.0585275558482044e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CFP,Properdin,18598,555,0.36 [0.24-0.54],7.929955621439865e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGA,Glycoprotein hormones alpha chain,21457,669,1.80 [1.62-1.99],1.4385982240217036e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CGREF1,Cell growth regulator with EF hand domain protein 1,21458,675,2.73 [2.33-3.19],1.9813070027798576e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHAD,Chondroadherin,18156,548,0.27 [0.22-0.32],1.047205979642584e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",18536,557,2.71 [2.32-3.17],8.340196387586565e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHCHD6,MICOS complex subunit MIC25,18520,556,2.23 [1.77-2.81],1.22646584878621e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHGA,Chromogranin-A,18578,554,1.67 [1.56-1.79],7.62338879152411e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHGB,Secretogranin-1,21598,671,1.74 [1.48-2.03],8.193864835165124e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHI3L1,Chitinase-3-like protein 1,21014,653,1.40 [1.30-1.51],4.005287210757056e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CHRDL1,Chordin-like protein 1,21497,674,2.14 [1.75-2.63],3.322284947415638e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CILP,Cartilage intermediate layer protein 1,18578,554,2.61 [2.22-3.07],7.841889512307844e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKAP4,Cytoskeleton-associated protein 4,21594,672,3.34 [2.75-4.07],7.084759011024564e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",21354,672,1.37 [1.23-1.54],4.7498982287066535e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC14A,C-type lectin domain family 14 member A,21457,669,2.69 [2.20-3.30],4.42817636871269e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC1A,C-type lectin domain family 1 member A,21059,656,1.72 [1.41-2.10],7.569732537590813e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4A,C-type lectin domain family 4 member A,21422,667,0.49 [0.41-0.59],6.39774722544204e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4D,C-type lectin domain family 4 member D,21422,667,1.63 [1.46-1.82],2.398871116402381e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC4M,C-type lectin domain family 4 member M,18550,554,0.63 [0.53-0.76],4.778590457105285e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC5A,C-type lectin domain family 5 member A,21384,673,1.99 [1.60-2.48],7.329302603901621e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC6A,C-type lectin domain family 6 member A,20960,653,1.73 [1.49-2.00],1.577281955848353e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLEC7A,C-type lectin domain family 7 member A,21702,676,1.69 [1.45-1.95],4.106145232383821e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLGN,Calmegin,18078,551,1.45 [1.23-1.71],6.877850786282321e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLMP,CXADR-like membrane protein,21645,675,4.42 [3.34-5.85],2.4249103445866734e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLSTN2,Calsyntenin-2,21702,676,2.19 [1.89-2.53],1.4226525111443862e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CLUL1,Clusterin-like protein 1,21418,674,0.54 [0.46-0.64],4.033718316941639e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN2,Contactin-2,21645,675,1.86 [1.59-2.17],1.514928176386313e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN3,Contactin-3,21457,669,2.92 [2.25-3.80],1.0637570640107758e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN4,Contactin-4,21457,669,2.68 [1.99-3.61],1.0557930601623682e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTN5,Contactin-5,21514,669,0.59 [0.48-0.71],1.5672473271734585e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CNTNAP2,Contactin-associated protein-like 2,21422,667,1.56 [1.33-1.82],1.9698955902196767e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL18A1,Collagen alpha-1(XVIII) chain,21543,673,5.87 [4.46-7.72],1.1004133002196662e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL1A1,Collagen alpha-1(I) chain,21718,679,0.40 [0.29-0.55],1.825675238594991e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL3A1,Collagen alpha-1(III) chain,18578,554,2.80 [2.00-3.92],1.825341365373191e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL4A1,Collagen alpha-1(IV) chain,21458,675,2.68 [2.28-3.15],3.2608476854663585e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL5A1,Collagen alpha-1(V) chain,18156,548,2.26 [1.90-2.69],3.114005793887916e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COL6A3,Collagen alpha-3(VI) chain,21718,679,2.91 [2.48-3.41],6.7295586903774195e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COLEC12,Collectin-12,21422,673,3.80 [3.04-4.75],1.3443057852911484e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,COMP,Cartilage oligomeric matrix protein,21248,664,0.49 [0.40-0.61],1.0069196395575659e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPA2,Carboxypeptidase A2,21590,671,2.42 [2.19-2.68],8.728808810536068e-68
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPE,Carboxypeptidase E,21471,671,0.65 [0.55-0.77],4.293287484516514e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPM,Carboxypeptidase M,21546,669,5.24 [4.27-6.41],1.3597192749375841e-57
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPQ,Carboxypeptidase Q,18546,554,2.49 [1.97-3.16],3.0887650261094836e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPVL,Probable serine carboxypeptidase CPVL,21601,674,1.64 [1.37-1.98],1.0708276387761933e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CPXM2,Inactive carboxypeptidase-like protein X2,18578,553,3.28 [2.46-4.36],3.939809954485538e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR1,Complement receptor type 1,18537,560,1.92 [1.53-2.41],2.231607959483624e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CR2,Complement receptor type 2,21560,669,1.88 [1.63-2.18],3.591333806029625e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CREG1,Protein CREG1,21174,662,0.50 [0.42-0.61],2.526263040731836e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRELD1,Protein disulfide isomerase CRELD1,18156,548,2.78 [2.22-3.47],2.035354006810026e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRH,Corticoliberin,20926,652,0.73 [0.67-0.80],8.211475464425798e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRHBP,Corticotropin-releasing factor-binding protein,21422,673,4.78 [3.70-6.18],6.373678201470169e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIM1,Cysteine-rich motor neuron 1 protein,21531,674,3.48 [2.54-4.79],1.2544484971552484e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRIP2,Cysteine-rich protein 2,21257,660,1.77 [1.49-2.09],3.8694540441902005e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRISP2,Cysteine-rich secretory protein 2,21645,675,0.72 [0.63-0.81],9.563238579402073e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRISP3,Cysteine-rich secretory protein 3,18431,558,0.39 [0.29-0.53],1.2634589415942683e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRNN,Cornulin,20865,652,0.80 [0.72-0.89],5.1261298918263286e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CRTAC1,Cartilage acidic protein 1,21718,679,0.51 [0.41-0.63],2.4584109001510646e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1,Macrophage colony-stimulating factor 1,21531,674,3.42 [2.70-4.34],1.6000987679105307e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF1R,Macrophage colony-stimulating factor 1 receptor,18602,560,2.32 [1.95-2.77],1.1895519325644347e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,21257,660,1.28 [1.14-1.43],3.112199191455737e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST3,Cystatin-C,21523,667,2.99 [2.43-3.68],3.086986836294119e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CST7,Cystatin-F,21458,672,1.15 [1.07-1.22],5.660892762486116e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CSTB,Cystatin-B,21165,666,1.54 [1.32-1.81],7.301621673538151e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTBS,Di-N-acetylchitobiase,18342,551,3.87 [2.78-5.40],1.3989190771745048e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTHRC1,Collagen triple helix repeat-containing protein 1,18578,554,2.50 [1.92-3.27],1.6639855490099208e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSD,Cathepsin D,20086,636,2.18 [1.89-2.51],2.2548672158476068e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSE,Cathepsin E,18156,548,3.04 [2.59-3.56],3.1446461202205533e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSL,Cathepsin L1,21458,675,2.20 [1.67-2.91],2.1634779805604408e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSO,Cathepsin O,21702,676,5.15 [4.16-6.38],7.080245145988173e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSS,Cathepsin S,16878,529,4.44 [3.10-6.37],4.2082672112114753e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CTSZ,Cathepsin Z,21495,667,3.63 [2.92-4.51],1.4911798081470155e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CUZD1,CUB and zona pellucida-like domain-containing protein 1,18078,551,1.47 [1.24-1.74],8.887267462739764e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXADR,Coxsackievirus and adenovirus receptor,21422,667,1.47 [1.28-1.68],4.4182198155284295e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL12,Stromal cell-derived factor 1,21092,665,0.62 [0.51-0.75],8.393900613870658e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL16,C-X-C motif chemokine 16,21681,678,3.00 [2.25-3.99],6.16993223281935e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,CXCL8,Interleukin-8,21315,665,1.37 [1.26-1.49],2.914416011693221e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DAG1,Dystroglycan,21531,674,1.54 [1.32-1.80],2.6513079786296985e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",21517,671,4.31 [3.55-5.23],3.9666774151867226e-49
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DCN,Decorin,21059,656,3.05 [2.30-4.05],9.69554886693766e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",21362,668,1.59 [1.37-1.84],1.5253587843320215e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DDR1,Epithelial discoidin domain-containing receptor 1,21651,672,2.47 [1.88-3.24],8.274437872491596e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFA1_DEFA1B,Neutrophil defensin 1,21022,653,1.27 [1.13-1.43],9.567133753219805e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DEFB103A_DEFB103B,Beta-defensin 103,17897,542,1.45 [1.24-1.70],4.549881800798967e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DIPK2B,Divergent protein kinase domain 2B,18156,548,0.50 [0.37-0.66],2.469199618673383e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK3,Dickkopf-related protein 3,21718,679,1.62 [1.29-2.05],4.3638134785964926e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DKK4,Dickkopf-related protein 4,21219,660,2.66 [2.33-3.03],1.1938228676456182e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DLL1,Delta-like protein 1,21517,671,4.66 [3.80-5.71],9.05183880699826e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMD,Dystrophin,18068,542,1.42 [1.22-1.65],4.463595163264497e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DMP1,Dentin matrix acidic phosphoprotein 1,18068,542,0.37 [0.33-0.42],9.622624073774608e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DNER,Delta and Notch-like epidermal growth factor-related receptor,21385,669,0.35 [0.27-0.47],1.539236759730011e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP10,Inactive dipeptidyl peptidase 10,21422,667,1.51 [1.27-1.80],4.25251999788294e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,21362,668,3.87 [3.16-4.75],1.523944604303586e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPT,Dermatopontin,21718,679,2.26 [1.68-3.04],6.40754918332013e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DPY30,Protein dpy-30 homolog,21583,672,1.45 [1.31-1.61],4.007521514127934e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DRAXIN,Draxin,21257,660,1.53 [1.30-1.80],2.709029190288429e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSC2,Desmocollin-2,21198,659,4.67 [3.89-5.60],2.5679493161629085e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSCAM,Down syndrome cell adhesion molecule,18543,553,2.64 [2.10-3.32],8.809005633205356e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG2,Desmoglein-2,21457,669,3.03 [2.35-3.91],1.6770556764474246e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DSG4,Desmoglein-4,21294,666,0.61 [0.53-0.71],6.809020366454345e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,DTNB,Dystrobrevin beta,18482,556,2.10 [1.79-2.45],1.0355470268811479e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EBI3_IL27,Interleukin-27,21619,674,2.44 [1.95-3.05],5.033871030772966e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",18578,553,1.33 [1.20-1.47],9.34496538241806e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,21645,675,3.07 [2.65-3.56],1.941873961111662e-50
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,21059,656,1.86 [1.54-2.25],1.4878526090142471e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EDN1,Endothelin-1,18068,542,2.98 [2.30-3.85],1.3591567558748687e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,18515,555,2.52 [2.02-3.15],2.3625003413604337e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,21524,668,3.04 [2.49-3.72],3.0218230001197928e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA1,Ephrin-A1,21417,668,4.18 [3.44-5.09],1.943125720880608e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EFNA4,Ephrin-A4,21218,660,4.89 [4.13-5.80],1.8570064357828054e-74
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFL7,Epidermal growth factor-like protein 7,20960,653,1.64 [1.38-1.96],1.9011827392791425e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EGFR,Epidermal growth factor receptor,21718,679,0.38 [0.25-0.59],1.2720894316858446e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,21718,679,2.39 [1.85-3.09],3.8959905858492647e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,21531,674,0.69 [0.60-0.78],2.34730024163373e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,18068,542,2.03 [1.58-2.60],2.1865756262742004e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,20804,647,1.29 [1.18-1.41],1.015480967358964e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,21059,656,0.32 [0.23-0.44],1.8470708342730454e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,21059,656,2.76 [2.04-3.74],6.396970979781938e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPCAM,Epithelial cell adhesion molecule,21418,672,0.76 [0.70-0.82],3.8252083006151455e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA1,Ephrin type-A receptor 1,21492,674,2.04 [1.63-2.56],5.403849232883376e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA2,Ephrin type-A receptor 2,20672,652,4.33 [3.61-5.18],1.0618309912317922e-56
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHA4,Ephrin type-A receptor 4,18156,548,2.33 [1.76-3.09],3.971119086039278e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHB4,Ephrin type-B receptor 4,21718,679,4.05 [3.20-5.13],2.8281751490844077e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPHB6,Ephrin type-B receptor 6,21229,659,2.21 [1.80-2.70],1.6835978874286822e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPO,Erythropoietin,21422,667,1.50 [1.39-1.61],4.6908235880079406e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,21609,673,2.85 [2.32-3.49],1.2182640460459017e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERBB4,Receptor tyrosine-protein kinase erbB-4,21517,671,2.71 [2.03-3.62],1.6345252006588587e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ERMAP,Erythroid membrane-associated protein,18027,543,1.93 [1.61-2.32],1.9395974309659098e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ESAM,Endothelial cell-selective adhesion molecule,21718,679,2.45 [2.01-2.99],1.0234728162442584e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F10,Coagulation factor X,18602,560,0.56 [0.43-0.74],4.4227394390424665e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F11R,Junctional adhesion molecule A,21457,669,1.31 [1.15-1.48],2.933406112039777e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F13B,Coagulation factor XIII B chain,18509,555,0.24 [0.17-0.32],2.460516660438232e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,F2R,Proteinase-activated receptor 1,21497,674,1.41 [1.24-1.60],1.2984556453543217e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP1,"Fatty acid-binding protein, liver",21422,673,1.84 [1.72-1.97],3.1609550767118973e-68
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP2,"Fatty acid-binding protein, intestinal",21458,675,1.32 [1.22-1.44],3.702735828804882e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP3,"Fatty acid-binding protein, heart",18578,553,1.99 [1.75-2.26],4.244635963170928e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP4,"Fatty acid-binding protein, adipocyte",21718,679,2.67 [2.36-3.00],7.56745228982975e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP5,Fatty acid-binding protein 5,21578,669,1.26 [1.14-1.41],1.653878035556057e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FABP6,Gastrotropin,21027,655,1.33 [1.19-1.50],7.5160196434433e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3B,Protein FAM3B,21362,668,5.04 [4.03-6.30],5.590406572920657e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3C,Protein FAM3C,21429,675,7.02 [5.70-8.65],3.935650583615797e-75
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAM3D,Protein FAM3D,18515,555,2.09 [1.89-2.31],6.1042853965402995e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FAS,Tumor necrosis factor receptor superfamily member 6,21643,677,1.72 [1.48-1.99],4.713681467866824e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FASLG,Tumor necrosis factor ligand superfamily member 6,21702,676,0.60 [0.49-0.73],2.3552909960716685e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FBLN2,Fibulin-2,18578,554,2.06 [1.63-2.61],1.291264888447096e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,18578,553,1.79 [1.60-2.00],1.5928684520011503e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCAR,Immunoglobulin alpha Fc receptor,21422,667,1.39 [1.20-1.61],9.286563879895554e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,21457,669,1.42 [1.27-1.59],1.4237864349651183e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,21378,666,1.33 [1.15-1.53],8.898471768431829e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCN2,Ficolin-2,21384,667,0.57 [0.49-0.66],3.3425749083573e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRL6,Fc receptor-like protein 6,21422,667,1.26 [1.13-1.40],2.041015319865788e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FCRLB,Fc receptor-like B,20960,653,1.32 [1.20-1.44],4.3764115900359505e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FDX1,"Adrenodoxin, mitochondrial",17937,539,1.29 [1.15-1.46],1.542341490987786e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF19,Fibroblast growth factor 19,21531,674,0.76 [0.69-0.83],5.184305876037767e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF21,Fibroblast growth factor 21,21619,674,1.26 [1.19-1.33],4.405403021032576e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF23,Fibroblast growth factor 23,21612,673,1.58 [1.43-1.74],1.952856495291412e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGF5,Fibroblast growth factor 5,21092,665,2.50 [2.07-3.02],3.3756369619643167e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP1,Fibroblast growth factor-binding protein 1,21517,671,0.16 [0.13-0.20],3.792482578453554e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP2,Fibroblast growth factor-binding protein 2,18578,554,0.38 [0.32-0.45],3.430858560626323e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFBP3,Fibroblast growth factor-binding protein 3,18536,557,0.41 [0.32-0.51],6.340805274460467e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGFR2,Fibroblast growth factor receptor 2,21517,671,6.28 [4.76-8.29],1.2537660540153402e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FGL1,Fibrinogen-like protein 1,18602,560,1.67 [1.48-1.89],4.183944213538448e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,21257,660,2.84 [2.24-3.59],4.1624076990778745e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FLT3LG,Fms-related tyrosine kinase 3 ligand,21702,676,1.93 [1.58-2.35],1.1298225512383368e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FN1,Fibronectin,18598,555,0.41 [0.30-0.56],2.686687511475877e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR1,Folate receptor alpha,21427,669,2.34 [1.90-2.89],2.4347408428246826e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FOLR2,Folate receptor beta,21651,672,2.35 [1.85-2.98],2.1777436765734054e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSHB,Follitropin subunit beta,18068,542,1.80 [1.54-2.11],4.94354487014819e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FST,Follistatin,21497,674,0.65 [0.56-0.76],1.278467783375474e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL1,Follistatin-related protein 1,18068,542,4.88 [3.46-6.88],1.5974945469204372e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FSTL3,Follistatin-related protein 3,21389,671,3.12 [2.60-3.73],3.940976364167793e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FTCD,Formimidoyltransferase-cyclodeaminase,18498,557,1.29 [1.18-1.42],6.502216513961664e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUOM,Fucose mutarotase,18156,548,1.33 [1.17-1.52],1.1611395609226782e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,21651,672,1.53 [1.31-1.77],3.0631371229986254e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAL,Galanin peptides,21531,674,0.76 [0.68-0.84],4.529503074870866e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,21362,668,3.01 [2.33-3.88],1.7502947954996414e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,21092,665,2.01 [1.72-2.35],1.7983735499840734e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GALNT7,N-acetylgalactosaminyltransferase 7,21362,668,7.95 [5.53-11.42],3.4531805701320465e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAS6,Growth arrest-specific protein 6,21583,674,2.04 [1.54-2.70],6.735277360174678e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GAST,Gastrin,18536,557,1.33 [1.27-1.40],4.8133098211886347e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCG,Pro-glucagon,20960,653,1.59 [1.50-1.69],1.4613728046838823e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,17709,537,1.40 [1.20-1.63],2.053511323633236e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",21362,668,2.22 [1.82-2.71],4.6553257055943024e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF15,Growth/differentiation factor 15,21718,679,6.32 [5.59-7.14],2.851761572639254e-193
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDF2,Growth/differentiation factor 2,21458,675,1.49 [1.22-1.82],8.023150167680051e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GDNF,Glial cell line-derived neurotrophic factor,20982,646,1.51 [1.26-1.81],1.0769238733540975e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA1,GDNF family receptor alpha-1,21619,674,5.72 [4.63-7.08],2.355501559969053e-58
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GFRA3,GDNF family receptor alpha-3,21188,659,2.20 [1.72-2.82],4.4078839215747615e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGH,Gamma-glutamyl hydrolase,21106,660,1.54 [1.26-1.90],3.733263040695155e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GGT5,Glutathione hydrolase 5 proenzyme,21257,660,7.70 [5.92-10.02],4.933221518310625e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GH1,Somatotropin,21429,675,1.10 [1.05-1.14],6.82915723534816e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHR,Growth hormone receptor,18156,548,0.43 [0.32-0.59],1.3416656240996385e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GHRL,Appetite-regulating hormone,21458,675,0.84 [0.77-0.91],3.58733662334668e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIMAP7,GTPase IMAP family member 7,18156,548,0.45 [0.33-0.62],1.11439104707455e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIP,Gastric inhibitory polypeptide,18068,542,1.61 [1.39-1.86],1.9594327672270763e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GIPC2,PDZ domain-containing protein GIPC2,18536,557,2.69 [2.15-3.37],7.67737280517209e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GKN1,Gastrokine-1,20585,632,1.77 [1.36-2.29],2.014168183867005e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GLA,Alpha-galactosidase A,18126,547,2.23 [1.81-2.76],1.2055009832439921e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GM2A,Ganglioside GM2 activator,18127,548,1.90 [1.62-2.23],2.0333876403236804e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GMPR,GMP reductase 1,21702,676,0.74 [0.65-0.85],2.5433518260868e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GNPDA2,Glucosamine-6-phosphate isomerase 2,18156,548,0.47 [0.37-0.59],7.179660477221845e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GOLM2,Protein GOLM2,21651,672,3.53 [2.64-4.71],1.1067910171859837e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,20782,648,1.20 [1.10-1.30],1.2969624871040693e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPA33,Cell surface A33 antigen,21362,668,0.68 [0.64-0.72],1.4119498130585662e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPC1,Glypican-1,21645,675,1.74 [1.37-2.22],6.37143388295275e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPC5,Glypican-5,21257,660,0.63 [0.55-0.72],7.499446701217843e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPD1,Glycerol-3-phosphate dehydrogenase,18520,556,1.67 [1.45-1.92],8.746999909131814e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPNMB,Transmembrane glycoprotein NMB,20877,660,3.37 [2.62-4.32],1.5553969745038173e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPR37,Prosaposin receptor GPR37,21059,656,1.81 [1.62-2.01],5.4119895181162156e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GPRC5C,G-protein coupled receptor family C group 5 member C,18520,556,1.65 [1.47-1.85],4.185707929395179e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRN,Progranulin,21339,663,4.26 [3.31-5.50],6.10490879215816e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GRPEL1,"GrpE protein homolog 1, mitochondrial",21362,668,1.56 [1.40-1.73],5.769208243435239e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSN,Gelsolin,18522,560,0.12 [0.08-0.18],1.6830234230075112e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GSR,"Glutathione reductase, mitochondrial",18507,560,0.42 [0.29-0.61],7.790727071496113e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GUCA2A,Guanylin,21343,669,1.91 [1.59-2.29],3.982290983885287e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,GZMB,Granzyme B,21422,667,0.63 [0.55-0.71],2.318869748312713e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAO1,Hydroxyacid oxidase 1,21645,675,1.28 [1.21-1.35],2.775610741391711e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR1,Hepatitis A virus cellular receptor 1,21610,674,2.48 [2.26-2.71],5.6806544287620564e-86
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HAVCR2,Hepatitis A virus cellular receptor 2,21457,669,3.06 [2.57-3.64],3.470440728775363e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEG1,Protein HEG homolog 1,18156,548,2.12 [1.57-2.86],8.381870386881436e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HEPH,Hephaestin,18578,553,9.00 [6.39-12.70],4.851484864394573e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HGF,Hepatocyte growth factor,21702,676,2.19 [1.83-2.61],5.888141391629337e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HIP1R,Huntingtin-interacting protein 1-related protein,18499,557,1.84 [1.62-2.10],4.173506094459138e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",21348,661,1.47 [1.21-1.78],9.210605909761804e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",21422,667,2.59 [2.10-3.19],7.441658454461923e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMCN2,Hemicentin-2,18123,548,1.53 [1.31-1.78],5.2069997986407684e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HMOX1,Heme oxygenase 1,21220,668,0.40 [0.34-0.47],3.20511174814318e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HNMT,Histamine N-methyltransferase,21162,659,1.58 [1.36-1.83],1.034031065006773e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HPGDS,Hematopoietic prostaglandin D synthase,20960,653,0.40 [0.33-0.49],4.405585578531175e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HRG,Histidine-rich glycoprotein,18509,555,2.39 [1.84-3.09],3.5722575291934004e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,18027,543,2.25 [1.84-2.75],2.94190303582e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,21422,667,0.41 [0.34-0.49],6.557203583743959e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPA2,Heat shock-related 70 kDa protein 2,18520,556,1.64 [1.35-2.00],5.336092556760109e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPB6,Heat shock protein beta-6,21645,675,1.98 [1.69-2.31],1.5564392665233756e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,21318,665,2.38 [1.91-2.96],8.926735143745676e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,HYAL1,Hyaluronidase-1,21371,666,6.43 [4.83-8.55],2.018181509996425e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM1,Intercellular adhesion molecule 1,21379,665,2.36 [1.88-2.96],9.970803527885096e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM2,Intercellular adhesion molecule 2,21718,679,1.89 [1.51-2.37],3.671023966512269e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM4,Intercellular adhesion molecule 4,21422,667,0.62 [0.54-0.71],5.734657401701872e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ICAM5,Intercellular adhesion molecule 5,21458,675,1.45 [1.25-1.69],9.05845435445132e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IDUA,Alpha-L-iduronidase,21645,675,2.01 [1.71-2.36],1.6860558979319818e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,18077,535,2.07 [1.70-2.53],5.221672177179206e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNGR1,Interferon gamma receptor 1,21531,674,2.02 [1.51-2.70],2.5811014537591645e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNGR2,Interferon gamma receptor 2,21257,660,1.62 [1.42-1.84],3.533473754757387e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IFNL1,Interferon lambda-1,20982,646,1.40 [1.21-1.63],5.0157737579398405e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF1R,Insulin-like growth factor 1 receptor,21362,668,2.53 [1.89-3.40],5.709164709210562e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGF2R,Cation-independent mannose-6-phosphate receptor,21457,669,2.02 [1.50-2.71],2.840067987986997e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP2,Insulin-like growth factor-binding protein 2,21687,678,1.32 [1.17-1.48],2.998309360189691e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP3,Insulin-like growth factor-binding protein 3,21560,669,0.37 [0.31-0.44],1.101813379872322e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP4,Insulin-like growth factor-binding protein 4,21197,659,2.46 [2.18-2.78],1.963010898673174e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP6,Insulin-like growth factor-binding protein 6,21381,665,1.93 [1.60-2.33],9.519734500041207e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBP7,Insulin-like growth factor-binding protein 7,21718,679,2.72 [2.30-3.21],3.425868944324464e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,21458,675,2.41 [2.01-2.89],2.0596871790442416e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGLC2,Immunoglobulin lambda constant 2,18574,553,2.09 [1.70-2.56],2.3942722444346858e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF3,Immunoglobulin superfamily member 3,21362,668,2.68 [2.31-3.11],1.916795245353986e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF8,Immunoglobulin superfamily member 8,21458,675,2.77 [2.26-3.39],7.590090387323968e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IGSF9,Protein turtle homolog A,18578,553,1.36 [1.24-1.49],7.298156814969277e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10,Interleukin-10,21092,665,1.19 [1.09-1.30],6.057214197809048e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL10RB,Interleukin-10 receptor subunit beta,21531,674,3.01 [2.45-3.70],1.2137969181268394e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12A_IL12B,Interleukin-12,21362,668,1.43 [1.31-1.56],1.6413830102127392e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12B,Interleukin-12 subunit beta,21702,676,1.65 [1.46-1.87],2.4749240372311002e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL12RB1,Interleukin-12 receptor subunit beta-1,21092,665,2.44 [2.02-2.93],7.550341256069499e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL15,Interleukin-15,21422,667,1.69 [1.37-2.08],1.092433202856954e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL15RA,Interleukin-15 receptor subunit alpha,21092,665,2.26 [1.85-2.76],2.6207782961634786e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL17C,Interleukin-17C,21092,665,1.57 [1.45-1.71],3.21861242742492e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18,Interleukin-18,21349,673,1.56 [1.34-1.81],8.66660121081945e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18BP,Interleukin-18-binding protein,21560,669,3.61 [2.97-4.39],4.816641388622515e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL18R1,Interleukin-18 receptor 1,21702,676,5.30 [4.30-6.53],3.4787952651440315e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL19,Interleukin-19,20916,658,1.33 [1.22-1.46],3.237512003677886e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1R2,Interleukin-1 receptor type 2,21384,672,3.57 [2.50-5.10],2.665940545565125e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RL1,Interleukin-1 receptor-like 1,21643,677,1.93 [1.66-2.26],1.0029658923706842e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL1RN,Interleukin-1 receptor antagonist protein,21386,668,1.75 [1.57-1.95],2.2168702130517846e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL2RA,Interleukin-2 receptor subunit alpha,21316,662,1.69 [1.44-1.97],4.252404460634176e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL3RA,Interleukin-3 receptor subunit alpha,21092,665,1.68 [1.35-2.09],3.281510920112166e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL4R,Interleukin-4 receptor subunit alpha,21422,667,2.34 [1.99-2.76],3.2644946777880544e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL5RA,Interleukin-5 receptor subunit alpha,21422,667,1.40 [1.24-1.57],2.9231410269579512e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6,Interleukin-6,21362,668,1.22 [1.12-1.33],2.3577586253627222e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IL6ST,Interleukin-6 receptor subunit beta,21458,675,6.32 [4.31-9.25],2.680808952229571e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,IMMT,MICOS complex subunit MIC60,18520,556,1.93 [1.67-2.23],3.8620408737008183e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBB,Inhibin beta B chain,18156,548,1.85 [1.60-2.13],1.8354591182668298e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INHBC,Inhibin beta C chain,21457,669,2.28 [1.87-2.79],7.951606475490184e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL3,Insulin-like 3,18536,557,0.82 [0.75-0.90],1.8769578162965192e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL4,Early placenta insulin-like peptide,18520,556,1.42 [1.24-1.63],6.104732960057355e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSL5,Insulin-like peptide INSL5,18515,555,1.28 [1.18-1.39],1.3018597649662084e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,INSR,Insulin receptor,18027,543,3.53 [2.25-5.53],4.033772503338894e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA11,Integrin alpha-11,21422,667,0.39 [0.31-0.48],4.669903895023668e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA2,Integrin alpha-2,18156,548,0.62 [0.49-0.79],9.25114934949298e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA5,Integrin alpha-5,21457,669,3.36 [2.56-4.41],2.805810470230457e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGA6,Integrin alpha-6,21422,667,0.69 [0.59-0.81],5.0173178311308185e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGAV,Integrin alpha-V,21645,675,0.11 [0.07-0.16],8.284230267646896e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB2,Integrin beta-2,21334,670,2.00 [1.57-2.54],1.3877223927044084e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB6,Integrin beta-6,21092,665,2.15 [1.70-2.71],1.1136704384039518e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGB7,Integrin beta-7,21645,675,1.60 [1.39-1.85],1.2269822181663595e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITGBL1,Integrin beta-like protein 1,18578,554,3.26 [2.76-3.85],1.188311138982608e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,21560,669,3.02 [2.49-3.66],2.5438372522793686e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JAM2,Junctional adhesion molecule B,21651,672,3.18 [2.56-3.96],3.205636458971717e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,JAM3,Junctional adhesion molecule C,18156,548,1.44 [1.23-1.68],6.49996706753411e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,21362,668,1.42 [1.20-1.67],3.501908979011724e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLB,Beta-klotho,20982,646,1.31 [1.18-1.44],8.538423170709844e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK11,Kallikrein-11,21311,665,1.98 [1.66-2.37],4.722076240113481e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK13,Kallikrein-13,20976,657,0.64 [0.54-0.74],1.5692337700097064e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK3,Prostate-specific antigen,18578,554,0.79 [0.73-0.85],2.090443898972132e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK4,Kallikrein-4,21645,675,1.89 [1.73-2.07],4.114296025391005e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLK7,Kallikrein-7,17713,536,0.50 [0.40-0.63],4.6301965945581414e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,21702,676,4.71 [3.98-5.56],2.8643766057355226e-74
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRD1,Natural killer cells antigen CD94,21702,676,1.52 [1.30-1.76],5.4914576286401046e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,18027,543,1.36 [1.17-1.57],4.239979851878248e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KLRK1,NKG2-D type II integral membrane protein,18536,557,1.87 [1.58-2.20],1.5383459935792909e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT18,"Keratin, type I cytoskeletal 18",21362,668,1.54 [1.43-1.66],1.2842836351425097e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT19,"Keratin, type I cytoskeletal 19",21384,667,1.90 [1.74-2.08],3.351539390137416e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,KRT8,"Keratin, type II cytoskeletal 8",17979,542,1.51 [1.42-1.61],2.4665321636285587e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAG3,Lymphocyte activation gene 3 protein,21362,668,2.14 [1.86-2.47],1.4979970385914477e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,21422,673,2.31 [2.03-2.64],6.545966489196191e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAMB1,Laminin subunit beta-1,18068,542,3.27 [2.45-4.36],8.912118524373504e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LAYN,Layilin,21229,659,3.84 [3.27-4.50],1.6163050739197925e-61
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LBP,Lipopolysaccharide-binding protein,21560,669,1.45 [1.29-1.64],1.3266012611648994e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCN15,Lipocalin-15,18543,553,1.70 [1.54-1.88],2.526813379763716e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCN2,Neutrophil gelatinase-associated lipocalin,20826,651,1.78 [1.51-2.09],4.299837068394463e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LCP1,Plastin-2,18578,554,0.55 [0.45-0.67],1.624041012702512e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LDLR,Low-density lipoprotein receptor,21506,671,0.72 [0.62-0.83],8.541069108419349e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEP,Leptin,21458,675,1.25 [1.12-1.39],7.555250010904096e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LEPR,Leptin receptor,21458,675,1.58 [1.28-1.96],2.679391098085208e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LETM1,Mitochondrial proton/calcium exchanger protein,18543,553,1.59 [1.38-1.83],1.4969397035288187e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS1,Galectin-1,21458,675,1.62 [1.34-1.95],5.888103815751392e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3,Galectin-3,21517,669,2.50 [1.97-3.15],2.002487203376989e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS3BP,Galectin-3-binding protein,18598,555,2.13 [1.71-2.65],1.894109475953969e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS4,Galectin-4,21422,673,4.32 [3.84-4.85],1.3656355761395878e-133
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGALS9,Galectin-9,21424,672,2.80 [2.28-3.44],8.858348451139466e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LGMN,Legumain,21531,674,1.67 [1.38-2.03],1.7638367533546468e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,21429,675,1.66 [1.34-2.07],3.6921514949910425e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,21718,679,2.08 [1.61-2.68],1.6554186351563454e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,21612,676,1.85 [1.50-2.29],1.539031359255329e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,21092,665,1.79 [1.54-2.08],5.3797328451322536e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LIPF,Gastric triacylglycerol lipase,18068,542,1.31 [1.15-1.49],6.915111243008651e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LMOD1,Leiomodin-1,18543,553,1.97 [1.64-2.36],2.526078842078656e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPL,Lipoprotein lipase,21458,675,0.54 [0.47-0.62],4.75243112054162e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LPO,Lactoperoxidase,20673,639,1.89 [1.69-2.13],3.846490138712102e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,21584,673,2.05 [1.69-2.49],6.214114546013933e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,17973,543,2.00 [1.53-2.62],4.561540612204253e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRP11,Low-density lipoprotein receptor-related protein 11,21458,675,2.30 [1.93-2.74],2.6353092875534424e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRC25,Leucine-rich repeat-containing protein 25,21362,668,1.46 [1.22-1.74],2.9517285052979463e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LRRN1,Leucine-rich repeat neuronal protein 1,21092,665,0.52 [0.44-0.62],5.529206258658906e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTA4H,Leukotriene A-4 hydrolase,21645,675,0.75 [0.66-0.86],1.3368614382644428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,21718,679,2.41 [1.98-2.92],5.0112513681254e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBP3,Latent-transforming growth factor beta-binding protein 3,20960,653,1.37 [1.21-1.54],4.372017895006848e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LTBR,Tumor necrosis factor receptor superfamily member 3,21310,671,2.30 [1.88-2.83],1.957625335077084e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY6D,Lymphocyte antigen 6D,21318,667,1.42 [1.21-1.66],2.1727928023803705e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY9,T-lymphocyte surface antigen Ly-9,21187,663,1.97 [1.58-2.47],3.182980458213231e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LY96,Lymphocyte antigen 96,21257,660,1.62 [1.34-1.94],3.2811468669240337e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD3,Ly6/PLAUR domain-containing protein 3,21349,663,1.76 [1.43-2.16],6.849840023452769e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYPD8,Ly6/PLAUR domain-containing protein 8,20960,653,1.37 [1.20-1.56],2.0767061910993392e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,18598,555,3.77 [2.49-5.71],3.495376177850141e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,21194,657,1.33 [1.18-1.49],2.2758202471842806e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAMDC2,MAM domain-containing protein 2,18578,553,2.49 [2.02-3.05],4.204525728727939e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MAN2B2,Epididymis-specific alpha-mannosidase,18578,553,1.39 [1.20-1.61],9.989574057745564e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MANSC1,MANSC domain-containing protein 1,21517,671,2.01 [1.58-2.57],1.9354100954619652e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MATN3,Matrilin-3,21218,660,0.33 [0.26-0.41],1.8829508333229532e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MB,Myoglobin,21718,679,1.29 [1.15-1.45],2.347599805986036e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,21257,660,1.38 [1.24-1.54],3.4898219636130073e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MDK,Midkine,21446,669,1.79 [1.59-2.02],1.2396916955805821e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEGF10,Multiple epidermal growth factor-like domains protein 10,21422,673,0.60 [0.50-0.72],3.836052252509052e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MENT,Protein MENT,18156,548,0.20 [0.14-0.28],1.7557801463343786e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEP1B,Meprin A subunit beta,21458,675,0.86 [0.81-0.91],4.707884962144233e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MEPE,Matrix extracellular phosphoglycoprotein,21422,673,0.36 [0.27-0.47],2.977249447691527e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MERTK,Tyrosine-protein kinase Mer,21702,676,2.01 [1.53-2.64],4.685941315950813e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFAP4,Microfibril-associated glycoprotein 4,18156,548,4.67 [3.66-5.96],2.1201573660565721e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MFGE8,Lactadherin,21457,669,2.04 [1.75-2.37],5.2410069334704953e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,21422,667,1.12 [1.06-1.19],8.947055573381131e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MILR1,Allergin-1,21092,665,1.63 [1.43-1.87],3.586924008323957e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MLN,Promotilin,21422,667,1.28 [1.18-1.39],5.8772573067622615e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MME,Neprilysin,21362,668,1.36 [1.25-1.48],4.163938351881919e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP1,Interstitial collagenase,20724,648,1.24 [1.14-1.35],9.508679838539948e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP10,Stromelysin-2,21385,672,1.88 [1.68-2.11],1.0650795073976532e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP12,Macrophage metalloelastase,21481,669,2.05 [1.82-2.30],1.0054927875043087e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP7,Matrilysin,21030,656,2.76 [2.38-3.21],4.774327550349448e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP8,Neutrophil collagenase,21617,672,1.26 [1.14-1.38],3.626954221968933e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MMP9,Matrix metalloproteinase-9,21427,669,1.27 [1.13-1.43],9.892886760451864e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MRC1,Macrophage mannose receptor 1,18602,560,4.65 [3.55-6.07],2.663197557055792e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MSR1,Macrophage scavenger receptor types I and II,21651,672,2.33 [2.00-2.70],7.302850646020098e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MUC13,Mucin-13,20982,646,4.58 [4.01-5.23],1.1632495613664835e-112
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MVK,Mevalonate kinase,21092,665,1.42 [1.31-1.54],3.3800330649756573e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MXRA8,Matrix remodeling-associated protein 8,18156,548,0.24 [0.18-0.32],1.1221316928600669e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYBPC1,"Myosin-binding protein C, slow-type",18578,553,1.26 [1.13-1.39],1.2890106039889275e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYBPC2,"Myosin-binding protein C, fast-type",18068,542,1.20 [1.10-1.31],5.375613667800143e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",18078,551,1.35 [1.19-1.52],3.108395250436576e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,MYOC,Myocilin,21457,669,0.71 [0.61-0.83],2.8120462247725067e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGK,N-acetyl-D-glucosamine kinase,18037,542,0.53 [0.45-0.62],2.3424198343656283e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,18156,548,2.81 [1.90-4.14],1.922968802415392e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,21517,671,3.99 [3.16-5.04],2.2342763166350806e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCAN,Neurocan core protein,21651,672,0.30 [0.25-0.37],4.841818533736378e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCR1,Natural cytotoxicity triggering receptor 1,21391,665,2.61 [2.19-3.10],2.381103753950797e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,18515,555,3.53 [2.89-4.30],2.20412516748856e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NCS1,Neuronal calcium sensor 1,21645,675,3.92 [3.10-4.94],1.0116916653542996e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN2,Nectin-2,21429,675,4.08 [3.37-4.96],3.2180403676599997e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NECTIN4,Nectin-4,21517,671,2.49 [2.09-2.95],1.5351982793813843e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NEFL,Neurofilament light polypeptide,20920,644,2.27 [2.00-2.58],3.32932330347338e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NELL1,Protein kinase C-binding protein NELL1,21517,671,0.34 [0.29-0.40],1.3111721581715104e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",21092,665,1.28 [1.14-1.43],1.8092156018044108e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NGRN,Neugrin,18536,557,1.96 [1.45-2.64],1.242916184780988e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NHLRC3,NHL repeat-containing protein 3,17731,538,4.16 [3.16-5.46],1.3841822855871511e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NME3,Nucleoside diphosphate kinase 3,21453,673,0.52 [0.38-0.71],3.9680980121110506e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS1,"Nitric oxide synthase, brain",20982,646,1.38 [1.22-1.54],7.94994060449031e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOS3,"Nitric oxide synthase, endothelial",20982,646,1.42 [1.26-1.59],3.759237126171821e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NOTCH1,Neurogenic locus notch homolog protein 1,21718,679,4.35 [2.86-6.62],7.452386941443142e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPC2,NPC intracellular cholesterol transporter 2,18266,549,3.93 [3.21-4.81],1.370928709827412e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPDC1,Neural proliferation differentiation and control protein 1,21458,675,2.13 [1.80-2.53],4.6220931124385024e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPPB,Natriuretic peptides B,21059,656,1.26 [1.20-1.33],3.068816747241285e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPTX1,Neuronal pentraxin-1,21457,669,1.55 [1.32-1.82],1.0687924651809663e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NPY,Pro-neuropeptide Y,21645,675,2.19 [1.93-2.48],5.629473266082775e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRCAM,Neuronal cell adhesion molecule,21458,675,4.74 [3.79-5.94],5.2319586024178215e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NRP1,Neuropilin-1,21594,670,7.09 [5.51-9.13],2.879573504575872e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,18536,557,2.15 [1.76-2.61],3.414868024717526e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTF3,Neurotrophin-3,21422,667,1.75 [1.45-2.11],4.8326229963341695e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTRK3,NT-3 growth factor receptor,21651,672,0.29 [0.21-0.40],1.5384497885945505e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,21458,675,1.43 [1.36-1.51],4.5346345637495773e-42
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,NUCB2,Nucleobindin-2,21613,673,1.49 [1.23-1.79],3.535197412812034e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OBP2B,Odorant-binding protein 2b,21181,659,0.71 [0.63-0.81],3.942750676255043e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OCLN,Occludin,18543,553,2.32 [1.99-2.72],5.263077569005907e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OGN,Mimecan,21457,669,2.06 [1.78-2.38],1.545910927876009e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OLFM4,Olfactomedin-4,17492,532,1.42 [1.32-1.54],4.177275849234925e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMD,Osteomodulin,21531,674,0.35 [0.30-0.41],2.3056804249531275e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OMG,Oligodendrocyte-myelin glycoprotein,21362,668,0.74 [0.67-0.82],5.542642162886895e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSCAR,Osteoclast-associated immunoglobulin-like receptor,21453,673,2.04 [1.66-2.52],2.280077396506205e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSM,Oncostatin-M,21316,663,1.23 [1.11-1.36],9.436635148987912e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,OSMR,Oncostatin-M-specific receptor subunit beta,21594,670,3.59 [2.50-5.15],4.607405945854497e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,21059,656,1.55 [1.37-1.74],4.600180547683412e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM,Paralemmin-1,18411,555,1.92 [1.53-2.41],1.7508263521310793e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PALM2,Paralemmin-2,18536,557,2.96 [2.48-3.52],5.6231737209453245e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PAPPA,Pappalysin-1,21092,665,0.66 [0.57-0.77],1.374590149756005e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,18122,548,1.50 [1.27-1.77],1.1861358927408755e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH1,Protocadherin-1,21635,673,2.21 [1.64-2.98],1.834675632749077e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH17,Protocadherin-17,21458,675,2.32 [1.95-2.76],3.3220573834919377e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDH7,Protocadherin-7,18515,555,1.63 [1.37-1.94],3.2652337015464054e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCDHB15,Protocadherin beta-15,18520,556,1.71 [1.41-2.07],2.9247988579847483e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PCSK9,Proprotein convertase subtilisin/kexin type 9,21718,679,2.36 [1.98-2.81],6.952420980371703e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1,Programmed cell death protein 1,21604,675,1.81 [1.56-2.09],3.0968498318437544e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDCD1LG2,Programmed cell death 1 ligand 2,21362,668,3.13 [2.52-3.88],2.2182255665429577e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDGFRA,Platelet-derived growth factor receptor alpha,21458,675,3.06 [2.41-3.88],2.437870480212638e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,18027,543,1.99 [1.71-2.31],2.869579748182465e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEAR1,Platelet endothelial aggregation receptor 1,21718,679,2.27 [1.66-3.10],2.981521492766552e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PENK,Proenkephalin-A,18156,548,1.61 [1.29-2.02],2.556951801038857e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PEPD,Xaa-Pro dipeptidase,18602,560,0.28 [0.20-0.38],4.316426944137081e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGA4,Pepsin A-4,18602,560,1.60 [1.44-1.78],6.230674361992111e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PGF,Placenta growth factor,21702,676,3.45 [2.77-4.31],6.904958991899058e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,21257,660,2.21 [1.73-2.82],1.609672644465907e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PI3,Elafin,21173,663,1.38 [1.23-1.55],5.418595487721415e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIGR,Polymeric immunoglobulin receptor,21183,659,4.69 [3.93-5.60],3.611876554214445e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,21457,669,4.29 [3.55-5.18],1.8889673452911253e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,21457,669,2.45 [2.07-2.90],3.521460407173985e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,21458,675,1.73 [1.51-1.98],3.4580757792562615e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PKD1,Polycystin-1,18578,553,5.89 [4.31-8.05],1.045401526242483e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G10,Group 10 secretory phospholipase A2,21257,660,1.78 [1.56-2.02],9.914641215801305e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G15,Phospholipase A2 group XV,21517,671,2.96 [2.32-3.78],3.603435296268725e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLA2G7,Platelet-activating factor acetylhydrolase,21457,669,0.12 [0.10-0.14],1.189889635253523e-90
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLAUR,Urokinase plasminogen activator surface receptor,21274,667,4.19 [3.37-5.22],1.5109373677778018e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLB1,"Phospholipase B1, membrane-associated",18536,557,0.65 [0.57-0.75],3.025737950262422e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLIN3,Perilipin-3,21458,675,1.60 [1.36-1.87],1.0290221212652284e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLTP,Phospholipid transfer protein,21659,677,0.62 [0.52-0.75],3.241411306339199e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PLXDC2,Plexin domain-containing protein 2,18536,557,2.54 [1.96-3.29],1.3060277485995068e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIP,Pancreatic triacylglycerol lipase,18602,560,1.44 [1.29-1.62],6.080150914539505e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PNLIPRP1,Inactive pancreatic lipase-related protein 1,18536,557,1.40 [1.27-1.55],9.47735560131484e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,POF1B,Protein POF1B,18027,543,2.01 [1.72-2.33],2.1225467013898413e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON1,Serum paraoxonase/arylesterase 1,18602,560,0.22 [0.17-0.29],3.892268532791529e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PON3,Serum paraoxonase/lactonase 3,21531,674,0.46 [0.38-0.56],2.567505325162366e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,18543,553,1.73 [1.44-2.07],2.066900687579112e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PPY,Pancreatic prohormone,21392,662,1.37 [1.28-1.47],1.2816684133261212e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRCP,Lysosomal Pro-X carboxypeptidase,21578,674,5.40 [4.36-6.68],4.0284154763922245e-54
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PREB,Prolactin regulatory element-binding protein,21092,665,2.03 [1.63-2.52],1.7329990731228303e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRG2,Bone marrow proteoglycan,18578,554,1.49 [1.28-1.74],4.096098576983951e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRND,Prion-like protein doppel,18536,557,1.53 [1.31-1.78],5.203917581246344e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PROS1,Vitamin K-dependent protein S,18598,555,0.53 [0.38-0.72],5.299743851429077e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRRT3,Proline-rich transmembrane protein 3,18068,542,1.57 [1.28-1.93],1.8979176967808536e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS2,Trypsin-2,21560,669,1.29 [1.15-1.44],8.90401221954567e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS22,Brain-specific serine protease 4,18027,543,1.63 [1.35-1.96],2.672462618340829e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS27,Serine protease 27,21384,673,1.44 [1.21-1.72],5.2908439070478166e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRSS8,Prostasin,21355,668,4.34 [3.70-5.08],3.0549901319438593e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PRTG,Protogenin,21645,675,2.05 [1.55-2.69],3.363784651727561e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSAP,Prosaposin,18407,553,3.16 [2.47-4.05],9.56137171768941e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,21257,660,1.30 [1.20-1.40],2.01145025048636e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGDS,Prostaglandin-H2 D-isomerase,21319,664,3.06 [2.55-3.65],2.10845310271057e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTGR1,Prostaglandin reductase 1,18578,553,1.40 [1.27-1.54],3.6292521761332138e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,21422,667,1.52 [1.32-1.77],1.810408203183614e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTK7,Inactive tyrosine-protein kinase 7,20982,646,2.60 [2.15-3.14],8.516396600456902e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTP4A3,Protein tyrosine phosphatase type IVA 3,18027,543,1.49 [1.29-1.72],3.8359493494829535e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRC,Receptor-type tyrosine-protein phosphatase C,18578,554,2.62 [1.91-3.59],2.330404014921893e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRH,Receptor-type tyrosine-protein phosphatase H,18515,555,1.69 [1.43-2.00],5.314208106177907e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,18515,555,2.30 [1.67-3.18],3.689023049967297e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRM,Receptor-type tyrosine-protein phosphatase mu,21389,666,1.96 [1.46-2.62],6.204040136775616e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,21191,659,1.96 [1.62-2.37],3.278650606512396e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTS,6-pyruvoyl tetrahydrobiopterin synthase,20874,643,1.39 [1.23-1.57],9.586390663352497e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PTX3,Pentraxin-related protein PTX3,21422,667,1.45 [1.23-1.71],7.4092385085997346e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PVR,Poliovirus receptor,21651,672,2.09 [1.75-2.48],7.897266976659354e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,PYY,Peptide YY,17937,539,2.01 [1.86-2.17],1.637812891816959e-68
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QPCT,Glutaminyl-peptide cyclotransferase,21464,672,2.67 [2.08-3.43],1.0960925547760232e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,QSOX1,Sulfhydryl oxidase 1,18236,547,1.66 [1.45-1.91],2.675473351774056e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RAB6A,Ras-related protein Rab-6A,21422,667,0.41 [0.35-0.49],1.9231677344851884e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES1,Retinoic acid receptor responder protein 1,20960,653,1.60 [1.35-1.89],4.443717509729045e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RARRES2,Retinoic acid receptor responder protein 2,21594,670,1.65 [1.45-1.88],1.6547764948695287e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBFOX3,RNA binding protein fox-1 homolog 3,18543,553,2.40 [2.06-2.80],4.7588105378230056e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP2,Retinol-binding protein 2,21362,668,1.52 [1.39-1.66],1.4626859314928752e-20
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP5,Retinol-binding protein 5,21362,668,1.78 [1.58-2.00],7.492460809066958e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RBP7,Retinoid-binding protein 7,18515,555,1.54 [1.38-1.72],4.6077221859402936e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,18068,542,2.68 [1.77-4.05],2.810744143024689e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1A,Lithostathine-1-alpha,21348,665,3.13 [2.80-3.50],9.023790756673944e-91
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG1B,Lithostathine-1-beta,21718,679,2.18 [1.98-2.40],1.7788341769946906e-55
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG3A,Regenerating islet-derived protein 3-alpha,21718,679,1.79 [1.63-1.97],4.723305930080617e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REG4,Regenerating islet-derived protein 4,21453,673,4.92 [4.33-5.60],2.184898778311841e-130
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RELT,Tumor necrosis factor receptor superfamily member 19L,21457,669,2.03 [1.66-2.49],9.215963737849962e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,REN,Renin,21458,675,2.42 [2.26-2.59],4.991109245380995e-141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,21362,668,1.96 [1.62-2.38],8.119273251508945e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RETN,Resistin,21406,672,1.42 [1.22-1.66],8.108867051286848e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RGMA,Repulsive guidance molecule A,21651,672,1.63 [1.30-2.03],1.6058620183707074e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,18156,548,1.80 [1.54-2.10],8.82640782011507e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE1,Ribonuclease pancreatic,18602,560,3.73 [2.90-4.80],9.83881658921802e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE10,Inactive ribonuclease-like protein 10,18068,542,1.68 [1.44-1.97],5.635601266276154e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE4,Ribonuclease 4,18010,543,3.19 [2.52-4.05],9.169402572625406e-22
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASE6,Ribonuclease K6,18483,557,2.81 [2.34-3.38],2.306676530743576e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNASET2,Ribonuclease T2,21612,676,5.17 [4.10-6.52],1.05691929270673e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RNF149,E3 ubiquitin-protein ligase RNF149,18068,542,3.47 [2.74-4.41],1.3601106691485922e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROBO1,Roundabout homolog 1,21453,673,2.30 [1.76-3.00],9.70345093872336e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,21458,675,1.60 [1.29-1.98],1.807813878536476e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RSPO3,R-spondin-3,21645,675,1.74 [1.39-2.19],1.7015266378173716e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,RTN4R,Reticulon-4 receptor,21645,675,5.73 [4.72-6.97],3.5873856440961607e-69
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A14,Protein S100-A14,18543,553,0.30 [0.24-0.37],1.1362400357756612e-28
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100A16,Protein S100-A16,20944,644,0.67 [0.59-0.77],1.7983049144647163e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100G,Protein S100-G,18543,553,0.64 [0.53-0.77],3.2433611328142047e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,S100P,Protein S100-P,21059,656,1.41 [1.26-1.58],1.661728702991003e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARA5,Scavenger receptor class A member 5,21651,672,3.47 [2.81-4.28],8.769846559961191e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARB2,Lysosome membrane protein 2,20827,643,3.18 [2.68-3.78],7.266356833782403e-40
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF1,Scavenger receptor class F member 1,21718,679,1.50 [1.27-1.77],1.265449975012037e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCARF2,Scavenger receptor class F member 2,21651,672,4.12 [3.28-5.18],3.9200746762224655e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCG2,Secretogranin-2,21552,671,5.58 [4.57-6.80],9.50528665353099e-65
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SCGN,Secretagogin,21092,665,2.92 [2.52-3.39],2.061663258050972e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDC1,Syndecan-1,21458,675,1.58 [1.34-1.85],2.700337115079288e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SDC4,Syndecan-4,21458,675,0.57 [0.49-0.66],1.3483691072904675e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEL1L,Protein sel-1 homolog 1,18068,542,2.21 [1.84-2.67],6.207793615267571e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELE,E-selectin,21718,679,2.12 [1.84-2.45],9.172299469101195e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SELPLG,P-selectin glycoprotein ligand 1,21422,667,2.00 [1.54-2.61],2.7601663130916905e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA3F,Semaphorin-3F,21458,675,1.96 [1.51-2.55],3.54966377724557e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA3G,Semaphorin-3G,18156,548,1.60 [1.36-1.89],1.9193068179986786e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEMA7A,Semaphorin-7A,21643,677,2.86 [2.33-3.51],5.306295621111704e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEPTIN8,Septin-8,18503,555,2.43 [1.97-2.99],1.538601823399996e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINA9,Serpin A9,21273,668,1.23 [1.11-1.35],3.312413587761854e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINF1,Pigment epithelium-derived factor,18315,550,3.41 [2.54-4.58],2.762677023153506e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SERPINI1,Neuroserpin,18126,547,0.40 [0.29-0.55],2.5105483812079644e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SETMAR,Histone-lysine N-methyltransferase SETMAR,21178,659,0.46 [0.37-0.59],1.3068703487691368e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SEZ6L,Seizure 6-like protein,21517,671,2.04 [1.59-2.60],1.2051193744033854e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SF3B4,Splicing factor 3B subunit 4,21362,668,0.81 [0.73-0.90],4.711742221208771e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFRP1,Secreted frizzled-related protein 1,21180,660,1.40 [1.21-1.62],6.654249423787298e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SFTPD,Pulmonary surfactant-associated protein D,21458,675,1.23 [1.11-1.37],6.526968139790489e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHBG,Sex hormone-binding globulin,18602,560,0.49 [0.41-0.58],7.023551448575761e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SHISA5,Protein shisa-5,18578,554,3.82 [3.03-4.82],6.873135083579389e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC1,Sialoadhesin,21531,674,2.81 [2.40-3.28],1.9928238413298542e-38
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC10,Sialic acid-binding Ig-like lectin 10,21422,667,2.64 [2.21-3.16],1.4295493113384034e-26
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC5,Sialic acid-binding Ig-like lectin 5,21457,669,1.23 [1.14-1.32],2.7163037188692026e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC6,Sialic acid-binding Ig-like lectin 6,21645,675,3.04 [2.50-3.68],1.3056938811934208e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC7,Sialic acid-binding Ig-like lectin 7,21458,675,2.80 [2.19-3.57],2.0649134093055616e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIGLEC8,Sialic acid-binding Ig-like lectin 8,18068,542,1.71 [1.43-2.06],6.228940635119055e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIRPB1,Signal-regulatory protein beta-1,21383,673,2.07 [1.79-2.39],1.8953720579530644e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,21092,665,2.10 [1.85-2.39],2.5599599601463924e-30
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF1,Signaling lymphocytic activation molecule,21092,665,1.71 [1.52-1.93],3.78842710669612e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF6,SLAM family member 6,20960,653,1.52 [1.27-1.80],2.62156503668456e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF7,SLAM family member 7,21422,667,1.45 [1.29-1.62],2.704812853618966e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLAMF8,SLAM family member 8,20960,653,1.70 [1.48-1.95],9.9754145026191e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC16A1,Monocarboxylate transporter 1,20982,646,1.27 [1.13-1.43],6.86095988354996e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,18515,555,1.38 [1.21-1.58],1.9369352759719705e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK2,SLIT and NTRK-like protein 2,21645,675,2.00 [1.68-2.37],4.683810033333209e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLITRK6,SLIT and NTRK-like protein 6,21059,656,2.72 [2.24-3.29],1.3572893885731251e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SLMAP,Sarcolemmal membrane-associated protein,18515,555,1.29 [1.17-1.43],2.200892292822305e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMAD5,Mothers against decapentaplegic homolog 5,21362,668,0.31 [0.22-0.43],2.300037717286825e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC1,SPARC-related modular calcium-binding protein 1,21645,675,2.03 [1.66-2.49],6.741816779343832e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMOC2,SPARC-related modular calcium-binding protein 2,21531,674,1.74 [1.48-2.06],6.788245776575235e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SMPD1,Sphingomyelin phosphodiesterase,21542,669,1.65 [1.44-1.89],3.273337087157689e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNAPIN,SNARE-associated protein Snapin,18543,553,0.64 [0.55-0.75],1.5717582135239872e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNCG,Gamma-synuclein,21257,660,1.50 [1.34-1.67],3.080104589981755e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",18068,542,1.92 [1.52-2.41],3.1940619073096934e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SORCS2,VPS10 domain-containing receptor SorCS2,20960,653,2.52 [2.10-3.02],2.0156771467340617e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK1,Serine protease inhibitor Kazal-type 1,21457,669,5.18 [4.53-5.93],4.435453039755474e-126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINK4,Serine protease inhibitor Kazal-type 4,21422,667,2.80 [2.54-3.08],2.7872204498233417e-98
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT1,Kunitz-type protease inhibitor 1,21378,668,2.40 [1.93-3.00],6.103557682733109e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPINT2,Kunitz-type protease inhibitor 2,21531,674,2.35 [1.97-2.80],4.5947161383130946e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPOCK1,Testican-1,21257,660,0.23 [0.18-0.31],1.4456343429348438e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON1,Spondin-1,21453,673,3.63 [3.01-4.38],1.5310913573935908e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SPON2,Spondin-2,21355,673,4.14 [3.44-4.98],1.6485179093488507e-51
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SRPX,Sushi repeat-containing protein SRPX,18578,553,1.64 [1.32-2.05],8.289251227343096e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",21362,668,1.36 [1.17-1.59],9.613877620125637e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",21718,679,1.74 [1.41-2.15],3.1937596934002733e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,STC1,Stanniocalcin-1,21651,672,1.36 [1.18-1.56],2.8617542331509285e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SULT2A1,Bile salt sulfotransferase,21422,667,1.34 [1.20-1.49],5.447246322493532e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUOX,"Sulfite oxidase, mitochondrial",18543,553,1.48 [1.31-1.67],3.1334606037632865e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD2,Sushi domain-containing protein 2,21457,669,1.88 [1.49-2.36],6.52862212104406e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,SUSD4,Sushi domain-containing protein 4,18520,556,1.72 [1.45-2.05],4.95013094869368e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TACSTD2,Tumor-associated calcium signal transducer 2,19014,591,2.28 [1.77-2.94],1.922001695887285e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TAFA5,Chemokine-like protein TAFA-5,21362,668,2.22 [1.88-2.62],4.025619019043651e-21
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCN2,Transcobalamin-2,21687,678,3.51 [2.88-4.28],1.1099719492981306e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TCOF1,Treacle protein,18578,553,1.89 [1.54-2.31],7.58519222393231e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TEK,Angiopoietin-1 receptor,21517,671,2.50 [1.82-3.42],1.4229489953982222e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TF,Serotransferrin,18598,555,4.89 [3.34-7.17],4.25256534833262e-16
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF1,Trefoil factor 1,21354,664,1.72 [1.60-1.85],7.466712800729632e-46
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF2,Trefoil factor 2,21497,674,2.40 [2.16-2.67],7.91974395955008e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFF3,Trefoil factor 3,21457,664,3.55 [3.08-4.10],1.5652067945636546e-68
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFPI,Tissue factor pathway inhibitor,21419,666,0.46 [0.36-0.58],2.3051998958336983e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFPI2,Tissue factor pathway inhibitor 2,21454,669,1.47 [1.27-1.70],1.432793730670642e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TFRC,Transferrin receptor protein 1,21553,670,1.59 [1.34-1.89],1.7223847565959389e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFA,Protransforming growth factor alpha,21422,667,2.24 [1.95-2.56],1.219834383837551e-31
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFB1,Transforming growth factor beta-1 proprotein,21667,674,1.53 [1.29-1.83],1.380558078923512e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,21350,665,0.50 [0.39-0.66],5.972650739401344e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR1,TGF-beta receptor type-1,18027,543,2.12 [1.55-2.89],2.1390838433611087e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGFBR2,TGF-beta receptor type-2,21517,671,2.77 [2.36-3.27],1.536623601471421e-34
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TGOLN2,Trans-Golgi network integral membrane protein 2,18602,560,2.35 [1.77-3.13],4.126890354433027e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBD,Thrombomodulin,21458,675,1.66 [1.33-2.07],9.13588839381334e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THBS2,Thrombospondin-2,21457,669,2.78 [2.40-3.21],2.241969445336446e-43
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,THY1,Thy-1 membrane glycoprotein,21651,672,2.61 [2.09-3.26],3.123170861777611e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,18257,549,1.65 [1.36-2.01],5.66097572540711e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TIMP1,Metalloproteinase inhibitor 1,21254,659,3.41 [2.76-4.22],1.2879119828970588e-29
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR1,Toll-like receptor 1,18027,543,1.95 [1.45-2.63],1.2305209551737924e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TLR3,Toll-like receptor 3,21702,676,1.31 [1.15-1.48],2.305345163843098e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TMPRSS15,Enteropeptidase,21362,668,1.73 [1.60-1.88],4.011430143037853e-39
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNF,Tumor necrosis factor,21029,655,1.87 [1.62-2.17],3.964961049861224e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,21257,660,3.63 [3.01-4.38],5.497612504238853e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,21257,660,1.81 [1.65-1.99],3.6547553605060865e-35
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,21702,676,3.92 [3.37-4.56],1.6177613025702567e-70
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,21422,673,3.06 [2.47-3.79],1.01647244999457e-24
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,21517,671,3.41 [2.88-4.03],9.282407825224403e-47
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,21453,673,1.60 [1.36-1.88],1.2700055683725771e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,21453,673,3.75 [3.09-4.55],2.0636270828931268e-41
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,21645,675,2.11 [1.77-2.50],4.9066593143014926e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,21457,669,4.46 [3.72-5.35],6.111349576760001e-59
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,21457,669,2.63 [2.26-3.05],6.237263328235457e-36
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,21651,672,2.35 [1.86-2.95],4.4408657114882803e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,21667,674,3.00 [2.57-3.49],3.754048149421109e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,21257,660,1.44 [1.29-1.61],9.946643065929163e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,21651,672,1.46 [1.26-1.69],4.819960465697622e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,21257,660,1.93 [1.70-2.20],4.864872030232481e-23
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF10,Tumor necrosis factor ligand superfamily member 10,21702,676,0.30 [0.22-0.39],2.877651588394802e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF11,Tumor necrosis factor ligand superfamily member 11,21422,667,0.63 [0.56-0.71],7.490829863483509e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF12,Tumor necrosis factor ligand superfamily member 12,21702,676,0.23 [0.18-0.30],1.0124237995716692e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,21531,674,3.68 [2.91-4.66],2.5830688974082192e-27
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,21681,678,1.94 [1.56-2.40],2.052660333733778e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,18578,554,2.07 [1.69-2.52],1.5675383518873817e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNN,Tenascin-N,18578,554,1.84 [1.52-2.24],7.939394908259927e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TNXB,Tenascin-X,21457,669,0.44 [0.34-0.57],8.337147710816362e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPK1,Thiamin pyrophosphokinase 1,18578,553,0.25 [0.18-0.34],6.596452346477584e-18
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TPP1,Tripeptidyl-peptidase 1,21284,671,1.59 [1.39-1.82],1.6915113565166072e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREH,Trehalase,18578,554,1.59 [1.41-1.80],1.5856289618290654e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,TREM2,Triggering receptor expressed on myeloid cells 2,21422,673,1.31 [1.16-1.48],2.305687245245881e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ULBP2,UL16-binding protein 2,21257,660,2.98 [2.56-3.47],2.0696898537258762e-44
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UMOD,Uromodulin,21643,676,0.42 [0.38-0.48],8.231615975971021e-48
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,UPB1,Beta-ureidopropionase,18578,553,1.37 [1.26-1.49],1.1292281702419285e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,USP28,Ubiquitin carboxyl-terminal hydrolase 28,18536,557,1.59 [1.33-1.89],1.826484021405408e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VASN,Vasorin,21140,662,2.14 [1.66-2.76],5.640425875577747e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,21362,668,0.21 [0.14-0.31],1.5081766007368353e-15
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VCAM1,Vascular cell adhesion protein 1,21527,669,4.12 [3.27-5.18],2.234830328662804e-33
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFA,Vascular endothelial growth factor A,21638,674,1.49 [1.33-1.68],1.8333170945894208e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VEGFD,Vascular endothelial growth factor D,21675,675,2.00 [1.67-2.40],1.2870032939494406e-13
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VMO1,Vitelline membrane outer layer protein 1 homolog,21362,668,1.41 [1.26-1.57],3.486910674240623e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VNN1,Pantetheinase,18602,560,1.56 [1.37-1.77],6.7197948995841495e-12
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,18520,556,2.51 [2.27-2.77],1.2165302335709118e-73
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,21427,665,3.14 [2.71-3.63],1.867920838754672e-52
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,21059,656,1.34 [1.20-1.48],6.163434416359876e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VTCN1,V-set domain-containing T-cell activation inhibitor 1,20960,653,1.55 [1.25-1.92],7.419910255652074e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,VWC2,Brorin,21190,659,2.06 [1.74-2.43],4.593734594456708e-17
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFDC2,WAP four-disulfide core domain protein 2,20381,635,2.41 [2.10-2.75],1.9158359312014023e-37
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",21178,659,0.50 [0.42-0.60],1.6202938558536635e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WIF1,Wnt inhibitory factor 1,21645,675,0.27 [0.22-0.34],2.9991075963817985e-32
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,WNT9A,Protein Wnt-9a,21092,665,2.66 [2.14-3.30],8.310680628816604e-19
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XCL1,Lymphotactin,21645,675,1.54 [1.38-1.73],4.9390681407552966e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XG,Glycoprotein Xg,21619,673,2.06 [1.71-2.47],1.6536750702676434e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,XPNPEP2,Xaa-Pro aminopeptidase 2,21517,671,0.81 [0.76-0.86],3.085345715966084e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,YAP1,Transcriptional coactivator YAP1,18536,557,3.42 [2.70-4.32],9.888568222673056e-25
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZBTB17,Zinc finger and BTB domain-containing protein 17,21059,656,1.37 [1.19-1.57],1.030670101297589e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,ZNRD2,Protein ZNRD2,18515,555,1.31 [1.17-1.47],4.373046561019128e-06
